Roth Capital Starts Rigel Pharmaceuticals (RIGL) at Buy

September 6, 2012 10:18 AM EDT Send to a Friend
Get Alerts RIGL Hot Sheet
Price: $3.75 +5.04%

Rating Summary:
    3 Buy, 7 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 9 | Down: 31 | New: 28
Trade RIGL Now!
Join SI Premium – FREE
Roth Capital initiates coverage on Rigel Pharmaceuticals (NASDAQ: RIGL) with a Buy. PT $15.00.

For an analyst ratings summary and ratings history on Rigel Pharmaceuticals click here. For more ratings news on Rigel Pharmaceuticals click here.

Shares of Rigel Pharmaceuticals closed at $9.89 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

Roth Capital

Add Your Comment